Open a bounty challenge Fund this gap and accept submissions. SPEC-033.
Composite
67%
Novelty
Mechanistic
Druggability
Priority
67%
Importance
67%
Tractability
Market price
50%

Description

A trial addressing TBI-dementia co-morbidity exists, but the representative papers lack mechanistic integration of repetitive TBI as a distinct pathomechanistic driver of AD pathology. Whether TBI accelerates amyloid aggregation, tau seeding, or neuroinflammation remains unresolved.